Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early intervention for renal papillary calcium spots in pilots
ChiCTR2200055859Phase 4Not yet recruiting
- Sponsor
- Air Force Specialty Medical Center
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of potassium sodium hydrogen citrate in Randall's plaque (RP) and nephrolithiasis (2 arms), sponsored by Air Force Specialty Medical Center. Primary endpoint: Renal papilla calcium plaque size. Planned start Jan 2021; status: not yet recruiting.
02
Drugs
potassium sodium hydrogen citrate
03
Conditions
Randall's plaque (RP)nephrolithiasis
Beyond the preview
Go deeper on ChiCTR2200055859.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200055859.